Melody, an ENU mutation in Caspase 3, alters the catalytic cysteine residue and causes sensorineural hearing loss in mice by Parker, Andrew et al.
Melody, an ENU mutation in Caspase 3, alters the catalytic
cysteine residue and causes sensorineural hearing loss in mice
Andrew Parker • Rachel E. Hardisty-Hughes •
Laura Wisby • Susan Joyce • Steve D. M. Brown
Received: 22 April 2010/Accepted: 8 November 2010/Published online: 30 November 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Progeny from the Harwell N-ethyl-N-nitrosou-
rea (ENU) recessive mutagenesis screen were assessed for
auditory defects. A pedigree was identiﬁed with multiple
progeny lacking response to a clickbox test. Auditory
brainstem response (ABR) analysis showed that homozy-
gous mutant mice were profoundly deaf and the line was
named melody. We subsequently mapped this mutation to a
6-Mb region on chromosome 8 and identiﬁed a point
mutation in melody that results in a C163S substitution in
the catalytic site of Caspase 3, a cysteine protease involved
in apoptosis. Melody fails to complement a null Caspase-3
mutant. Scanning electron microscopy (SEM) has revealed
disorganised sensory hair cells and hair cell loss. Histo-
logical analysis of melody has shown degeneration of spiral
ganglion cells in homozygote mice, with a gradient of
severity from apical to basal turns. Melody heterozygotes
also show evidence of loss of spiral ganglion neurons,
suggesting that the C163S mutation may show dominant
negative effects by binding and sequestering proteins at the
active site. The melody line provides a new model for
studying the role of Caspase 3 in deafness and a number of
other pathways and systems.
Introduction
N-ethyl-N-nitrosourea (ENU) mutagenesis in the mouse
has played an important role in identifying genes involved
with a number of disease systems (Justice et al. 1999). By
carrying out wide-ranging phenotypic screens on mice
carrying dominant and recessive ENU mutations, the
functional effects of these mutations can be investigated
(Brown et al. 2005; Hrabe de Angelis et al. 2000). The
large-scale ENU mutagenesis program at MRC Harwell
originally focused on dominant ENU mutations (Nolan
et al. 2000), but it has expanded to screen mice for both
dominantly and recessively inherited ENU mutations. Both
phenotype-driven and gene-driven screens have helped
identify many novel genes and alleles of existing genes
involved with hereditary deafness and hearing loss (Brown
et al. 2008).
Caspases are a group of cysteine proteases that play an
essential role in programmed cell death (PCD) caused by
apoptosis (Nicholson 1999). Caspases (cysteinyl aspartate-
speciﬁc proteases) cleave substrates directly after an
aspartic acid residue (Cohen 1997). Caspases share several
structural similarities, all containing an N-terminal pro-
domain followed by a large subunit approximately 20 kDa
in size (p20) and a small subunit of roughly 10 kDa (p10).
They are synthesised in a dormant form and require pro-
teolysis by cleavage at speciﬁc aspartate residues to
become mature (Earnshaw et al. 1999). There are at least
14 mammalian caspases, which are classiﬁed according to
their function and structure. Group I, comprising Caspases
1, 4, 5, 11, 12, 13, and 14, are known as the inﬂammatory
caspases. Groups II and III are known as the apoptotic
caspases. Group II caspases are the upstream initiator
caspases that mediate the apoptotic response and consist of
Caspases 2, 8, 9, and 10 and are activated by apoptotic
signalling pathways. Downstream are the executioner
caspases, Group III, comprising Caspases 3, 6, and 7, that
are activated by the initiator caspases and represent the
subclass of the caspase family that perform the proteolytic
cleavage of apoptotic target proteins (Lavrik et al. 2005).
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executioner caspases and is either partially responsible or
essential for the cleavage of many speciﬁc proteins during
apoptosis (Cohen 1997).
We have identiﬁed a new deafness mutant melody from
the ENU recessive screen at MRC Harwell. Homozygote
melody mice display severe sensorineural hearing loss and
hair cell and stereocilia bundle defects, similar to that
reported for Casp3 knockout mice (Morishita et al. 2001;
Takahashi et al. 2001). We have characterised in detail the
effects of the mutation on the spiral ganglion and have
revealed a gradient of severity across the cochlear turns as
well as evidence of dominant effects in the heterozygote.
We show here that the melody mutant carries a point
mutation in Caspase 3 that changes the key catalytic cys-
teine residue to serine. This exact substitution is often
employed in vitro for the study of Caspase-3 activity (Bose
and Clark 2005; Feeney and Clark 2005; Gu et al. 1995;
Kang et al. 2008; Van Criekinge et al. 1996) and as such
melody provides a complementary in vivo model.
Materials and methods
Mice
All animals were housed and maintained in the Mary Lyon
Centre at the MRC Harwell, under speciﬁc pathogen-free
(SPF) conditions in individually ventilated cages, with
environmental conditions as outlined in the Home Ofﬁce
Code of Practice. Animal procedures were carried out in
line with Home Ofﬁce regulations, and mice were eutha-
nized by Home Ofﬁce Schedule 1 methods.
The melody mutant line was derived from a recessive
pedigree from the ENU mutagenesis screen at the MRC
MGU Harwell. ENU-treated G0 C57BL/6 male mice were
mated to C3H female mice to produce G1 progeny. Female
G1 mice were backcrossed to the ENU-treated G0 founder
male to produce G3 mice which were screened for phe-
notypes caused by recessive mutations. The melody line
wasmaintainedonaC3Hgeneticbackgroundbyoutcrossing
and intercrossing successive generations. Caspase-3 null
mice (B6.129S1-Casp3
tm1Flv/J) were imported from The
Jackson Laboratory (Bar Harbor, ME, USA) and rederived
by in vitro fertilisation by the FESA core in the Mary Lyon
Centre to maintain SPF status. The null mice were continu-
ally backcrossed to C3H.
Clickbox
Mice were placed in the palm of the hand and tested with a
clickbox (Institute of Hearing Research, Nottingham, UK),
which produces a brief audio stimulus of * 20-kHz tone at
90 dB when held 30 cm away from the subject. Mice with
unaffected hearing display the ‘‘preyer’’ response, a back-
wards ﬂick of the ear pinnae. In most cases the preyer
reﬂex is followed by a startled response that can range from
a contracting of the neck muscles to a rapid jump back-
wards. A lack of either of the responses was recorded as no
response to the clickbox (Hardisty-Hughes et al. 2010).
Auditory-evoked brainstem response analysis (ABR)
(see Hardisty-Hughes et al. 2010)
Mice were anaesthetised with ketamine (Ketaset
TM) and
medetomidine (Domitor
TM) (0.5 ml Domitor at 100 mg/ml
with 4.12 ml water and 0.38 ml Ketaset at 1 mg/ml;
administered at a rate of 0.1 ml/10 g body weight). Ani-
mals were placed on a heated mat in an audiometric
chamber (IAC 401-A-SE). Electrodes (Grass Telefactor
F-E2-12) were placed subdermally over the vertex (active),
right mastoid (reference), and left mastoid (ground). ABR
responses were collected, ampliﬁed and averaged using
TDT system III hardware and software (Tucker Davis
Technology, Alachua, FL, USA). Click stimuli consisted of
a 0.1-ms broadband click of alternating polarity. Tone-
burst stimuli totalled 7-ms duration, including 1-ms rise/
fall time; frequencies used were 8, 12, 20, and 26 kHz.
Genetic mapping
Extraction of DNA from mouse ear biopsies and PCR were
performed using standard protocols. Single nucleotide
polymorphism (SNP) markers, polymorphic between the
parent C57BL/6 and C3H strains, were selected using the
Mouse Phenome Database (MPD) (http://phenome.jax.org/
pub-cgi/phenome/mpdcgi?rtn=snps/door). An initial gen-
ome scan using DNA from affected G3 mice was performed
using a panel of SNP markers by pyrosequencing on a PSQ
HS 96A pyrosequencer (Biotage AB). After linkage was
found,ﬁnemappingwasperformedbyselectingfurtherSNP
markers to narrow the nonrecombinant region.
Candidate gene selection and mutation detection
A list of genes that map to the nonrecombinant region
identiﬁed in the genome scan was obtained using the
Ensembl database (http://www.ensembl.org/Mus_musculus/
Info/Index). Candidates were selected by searching the
Mouse Genome Informatics (MGI) database (http://www.
informatics.jax.org/searches/allele_form.shtml) for genes
known to be connected with hearing loss. Primers were
designedaroundtheexonsofcandidategenes,andDNAfrom
melody homozygote, heterozygote, and both parental strains
was PCR ampliﬁed and sent for genetic sequencing (Gene-
service, Oxford, UK). For mutation detection the resulting
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software.
Genotyping
The melody (Casp3
mldy) mutation introduced a SmaI
restriction site. This enabled a genotyping assay to be
performed by PCR ampliﬁcation of exon 6 of Casp3 with
the primers 50-CTT CCT AGT TCT CAG ACC ACA CTT-
30 and 50-CAT TTT CTC ACC AGG TGC TGT-30,
yielding a product of 225 bp. Upon digestion with SmaI,
only the 225-bp band is visible in ?/? genomic DNA, two
bands of 100 and 125 bp can be seen in Casp3
mldy/
Casp3
mldy, and all three bands are present in Casp3
mldy/?.
Casp3
tm1Flv mice were genotyped by PCR ampliﬁcation in
accordance with the protocol outlined on The Jackson
Laboratory website (http://jaxmice.jax.org/protocolsdb/
f?p=116:2:954450999895056::NO:2:P2_MASTER_PROT
OCOL_ID,P2_JRS_CODE:3892,006233).
Histological analysis (see Hardisty-Hughes et al. 2010)
Animals were euthanized by cervical dislocation. The
heads were removed, skinned, and bisected down the
midline before ﬁxation by submersion in 10% neutral
buffered formaldehyde. Fixed specimens were decalciﬁed
and embedded in parafﬁn. Five-micrometre-thick sagittal
sections were obtained and stained with H&E according to
standard protocols. For spiral ganglion neuron density
measurements, slides were digitally scanned using a
Hamamatsu NanoZoomer slide scanner and the area con-
taining the spiral ganglion neurons (Rosenthal’s canal) was
calculated using NDP serve software. Spiral ganglion
neurons were counted (no distinction was made between
Type I and II cells) and normalised to the calculated area.
A Levene test of homogeneity of variances was performed
and subsequent statistical analysis was performed using an
ANOVA. As a result of the Levene test, Tamhane post hoc
analysis was used for the mid and basal turns, and Tukey
HSD post hoc analysis was used for the apical turn in SPSS
software (SPSS, Inc., Chicago, IL).
Scanning electron microscopy (see Hardisty-Hughes
et al. 2010)
Animals were euthanized and heads skinned and bisected as
previously described. Inner ears were dissected and ﬁxed in
2.5% glutaraldehyde in a 0.1 potassium phosphate buffer
solution for 3–4 h before decalciﬁcation by submersion in
4.3% EDTA for 48 h. Fine dissection was performed to
remove the cochlear shell and stria-vascularis before
osmiumtetroxide–thiocarbohydrazide(OTOTO)processing
(adapted from Hunter-Duvar 1978) was utilised to preserve
stereocilia structure. Specimens were then dehydrated by
submersion in ethanol solutions of increasing strength and
stored in acetone until critical-point drying was performed
using Emitech K850 (EM Technologies Ltd, Ashford, Kent,
UK). Sputter coating was achieved using a Polaron instru-
ments Inc. E5100. The specimens were examined with a
Hitachi S-530 scanning electron microscope.
Protein extraction and fractionation
Protein was extracted using CelLytic NuCLEAR Extrac-
tion kit (Sigma-Aldrich, NXTRACT-1KT 078K4112).
E17.5 heads were lysed in 19 lysis buffer containing
protease inhibitors using a glass homogenizer. Nuclei were
pelleted by centrifugation, and the cytoplasmic fraction
contained in the supernatant was separated. Ten micro-
grams of each cytoplasmic protein sample were run on a
12% Bis-Tris minigel (Invitrogen, NP0341BOX); the
nuclear fraction was discarded.
Western blotting
Protein was transferred onto a nitrocellulose membrane
(Invitrogen LC2000) and blocked in TBS containing 5% dry
skimmed milk and 0.1% Tween 20. The membrane was
incubated with a Caspase-3 antibody (Cell Signalling #9662)
at 1:500 dilution in blocking solution overnight at 4C. Sec-
ondary anti-rabbit HRP-conjugated antibody (Sigma Aldrich
A4914) was used at 1:10,000 dilution in blocking solution for
1 hatroomtemperature.Membraneswerewashedfourtimes
after both primary and secondary antibody incubations in
TBS ? 0.1% Tween 20. Enhanced chemiluminescence
(GEHealthcare,RPN2109)wasusedasthedetectionsystem.
An a-tubulin antibody (Abcam, ab15246) at 1:500 dilution
was used as described above as a loading control.
Results
Identiﬁcation of the melody mutant
The melody (mldy) mutant was identiﬁed from a recessive
ENU sensory screen undertaken at the MRC Mammalian
Genetics Unit, Harwell (see ‘‘Materials and methods’’).
The founder G3 mice carrying the melody mutation
appeared slightly smaller than littermates and had no
response to a clickbox. Some mutants were observed to
have cranial protuberances (Fig. 1).
Genetic mapping and candidate gene selection
An initial genome scan using a total of 13 progeny [both
G3 progeny (n = 2) and G5 progeny (n = 11)] showed
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affected mice (from subsequent generations to G11) with
SNP markers narrowed the mutant locus to approximately
6 Mb between the markers rs32804682 and rs37373014, a
region containing approximately 60 genes. In this region
there were a number of candidate genes that had known
mutations demonstrating a hearing loss phenotype. Caspase
3 represented a good candidate as mice lacking Caspase 3
were reported to have similar phenotypic traits to those
observed in mldy/mldy mice (Kuida et al. 1996; Morishita
et al. 2001; Takahashi et al. 2001).
DNA from mldy/mldy and mldy/? mice was PCR
ampliﬁed using primers for each of the six exons of Casp3
and the sequence examined for mutations. The sequence
contained a G-to-C transversion of nucleotide 489 of Casp3
located in exon 6 (Fig. 2a), causing a nonconservative
cysteine-to-serine change at amino acid 163. The residue
changed by the melody mutation is the catalytic cysteine of
murine Caspase 3 and is highly conserved through evolu-
tion (Fig. 2b). Not only is this catalytic cysteine conserved
in Caspase 3, it is central in the pentapeptide active site
motif QACXG (X being R, G, or Q) conserved in all
caspases (Cohen 1997) (Fig. 2c).
Complementation testing and phenotyping
We undertook to conﬁrm our identiﬁcation of the melody
(Casp3
mldy) mutation by complementation testing with the
Caspase-3-null mutant Casp3
tm1Flv. Moreover, in parallel
we carried out an extensive and detailed auditory and
phenotypic analysis of both melody and null mutations as
well as compound genotypes.
Fig. 2 A Caspase-3 mutation in the melody mutant. a Sequence at and
aroundnucleotide489(highlightedbyredovals)oftheexonicsequence
ofCasp3.Thesequenceshowscytosineatnucleotide489intheC57BL/
6 J and C3H parental strains and guanine at the same point in the
Casp3
mldy/Casp3
mldysequence.TheCasp3
mldy/? sequenceshowsboth
cytosine and guanine. Note that the reverse complement sequence is
shown; therefore, the melody mutation is G489C. b Evolutionary
conservation of the catalytic cysteine residue of Caspase 3 altered to
serineinthemelodymutant(blackbox).cConservationoftheQACXG
pentapeptide active site motif (black box), which is present in all
caspases. An alignment of peptide sequences from all the murine
caspases is shown; the residue number refers to Caspase 1
Fig. 1 a An example of an abnormal growth on the head of a mldy/
mldy mouse, probably due to hyperplasia of various cells in the brain.
b, c A comparison of ?/? (b) and mldy/mldy (c) mice with abnormal
protrusions from the brain at E17.5. This phenotype was seen in 50%
of mldy/mldy embryos examined and probably results in embryonic
lethality in most cases, leading to the lower than expected numbers of
mldy/mldy born (11.4%)
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We generated 537 intercross offspring from Casp3
mldy/
? matings and assessed them for auditory function with a
clickbox at four weeks of age. Of these, 61 mice (11.4%)
were deaf by clickbox as they did not exhibit the preyer
reﬂex or any form of startle response. All of these mice
were genotyped as Casp3
mldy/Casp3
mldy. In contrast, all
Casp3
mldy/? and ?/? mice showed a preyer reﬂex in
response to the clickbox.
We generated 68 offspring from matings of Casp3
mldy/
Casp3
mldy mice to Casp3
tm1Flv/? mutants. From these
progeny, 23 (33.8%), all of which genotyped as Casp3
mldy/
Casp3
tm1Flv, showed no response to the clickbox at four
weeks of age, indicating noncomplementation and con-
ﬁrming that a mutation in Caspase 3 is the cause of deaf-
ness in melody mutants. We also generated 159 progeny
from Casp3
tm1Flv/? intercross matings. From these, 18
(11.3%) were genotyped as Casp3
tm1Flv/Casp3
tm1Flv, none
of which showed a response to the clickbox at four weeks
of age. In contrast, all Casp3
tm1Flv/? and ?/? mice
showed the preyer response to the clickbox.
Embryonic phenotyping
The number of Casp3
mldy/Casp3
mldy mice born is signiﬁ-
cantly lower than the 25% that would be expected
according to Mendelian inheritance from a recessive mat-
ing scheme (v
2 P = 3 9 10
-13). To investigate this fur-
ther, we opened up females from two intercrosses, one
Casp3
mldy/?9Casp3
mldy/? and one Casp3
mldy/Casp3
mldy
9 Casp3
mldy/? , and harvested 19 embryos at 17.5 dpc. Of
these, six were genotyped as Casp3
mldy/Casp3
mldy and 50%
of these displayed severe blebs on their head (Fig. 1c),
possibly due to hyperplasia of the brain, which may have
led to prenatal losses.
ABR analysis
We analysed both melody and Casp3-null mice by ABR to
establish in detail the nature of the hearing impairment.
Twelve-week-old Casp3
mldy/Casp3
mldy mice (n = 5) were
subjected to tone-burst ABR assessment. None of the
Casp3
mldy/Casp3
mldy mice showed an ABR response at any
of the test frequencies, 8, 12, 20, and 26 kHz, at the
maximum level tested, 90 dB SPL (for graphical repre-
sentation, this was recorded as a threshold of 100 dB SPL).
In contrast, ?/? mice all showed threshold levels typical
for wild-type mice of the same age (Fig. 3a, b). Because no
ABR response was seen at any frequencies using tone
bursts, it was deemed that further ABR assessment using a
click stimulus would be sufﬁcient to characterise the
deafness phenotype.
To conﬁrm the lack of a heterozygous deafness pheno-
type, an outcross litter arising from a Casp3
mldy/Casp3
mldy
to C3H mating was tested at 14 weeks of age. These mice
(all Casp3
mldy/?) had click ABR thresholds between 20
and 25 dB SPL (data not shown). An additional 23 animals
between 4 and 8 weeks of age and arising from melody
intercross matings were tested by click ABR. There were
four Casp3
mldy/Casp3
mldy mice in this group, all of which
failed to show response to the click ABR stimulus at the
maximum level tested (90 dB SPL). All ?/? and
Casp3
mldy/? mice had click ABR thresholds ranging from
15 to 30 dB SPL (Fig. 3c).
A total of 27 progeny from Casp3
tm1Flv/? intercross
matings underwent click ABR testing at 8 weeks of age
(Fig. 3c). From these, four genotyped as Casp3
tm1Flv/
Casp3
tm1Flv and showed no response to the click stimulus
at 90 dB SPL. All Casp3
tm1Flv/? and ?/? mice had ABR
thresholds between 20 and 25 dB SPL. As expected, click
ABR performed on 8-week-old offspring from the com-
plementation matings demonstrated that Casp3
mldy/
Casp3
tm1Flv mice (n = 11) failed to elicit any response to
the 90 dB SPL click stimulus. A summary of the click
ABR data can be seen in Fig. 3c.
We also carried out ABRs to determine if there was
evidence of hearing loss at earlier time points and analysed
a small number of mice for each genotype at two weeks.
These included two Casp3
mldy/Casp3
mldy and two
Casp3
tm1Flv/Casp3
tm1Flv mice, all of which failed to show a
response to a 90-dB-SPL click ABR stimulus. Four
Casp3
mldy/Casp3
tm1Flv mice were also tested: three failed to
show a response to the highest-level click stimulus and one
had a click ABR threshold of 75 dB SPL. All ?/? (n = 7)
and heterozygote mice [Casp3
tm1Flv/? (n = 11), Casp3
mldy/
? (n = 4)] had ABR thresholds between 20 and 35 dB
SPL, with the exception of one Casp3
tm1Flv/? mouse which
had a threshold of 50 dB SPL. This mouse was very small
compared to littermates and it is possible this elevated
threshold was due to either ill health or difﬁculties with
electrode placement because of the very small size of the
animal. These data show that by two weeks of age, shortly
after the onset of hearing in mice, Casp3
mldy/Casp3
mldy,
Casp3
tm1Flv/Casp3
tm1Flv, and Casp3
mldy/Casp3
tm1Flv already
display severe hearing loss.
Western blot analysis
We analysed protein levels in both melody and Casp3-null
mutants as well as in compound genotypes. Caspase 3 is
located mainly in the cytoplasm in its uncleaved form.
Therefore, we proceeded to fractionate the total protein
into cytoplasmic and nuclear fractions. Cytoplasmic pro-
tein extracted from E17.5 heads from all genotypic variants
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no signiﬁcant difference in Caspase-3 levels between
Casp3
mldy/? , C3H, and ?/? mice (C3H/C57BL/6 J).
Caspase-3 levels were signiﬁcantly lower in Casp3
mldy/
Casp3
mldy mice compared to controls, and although not
signiﬁcantly different than in controls, the levels in
Casp3
mldy/? mice were intermediate between wild-type
and Casp3
mldy/Casp3
mldy mice. Casp3
tm1Flv/? levels were
around half that seen in wild-type mice and levels in
Casp3
mldy/Casp3
tm1Flv mice were further reduced. In
addition, protein levels in Casp3
tm1Flv/? and Casp3
mldy/
Casp3
tm1Flv were signiﬁcantly lower when compared with
that in Casp3
mldy/? (P B 0.05). As expected, the level of
Caspase 3 in the Casp3
mldy/Casp3
tm1Flv was signiﬁcantly
lower than in Casp3
mldy/Casp3
mldy mice (P B 0.05).
Casp3
tm1Flv/Casp3
tm1Flv animals were conﬁrmed as null by
the lack of any observable protein.
Scanning electron microscopy
Scanning electron micrographs (SEM) were obtained from
Casp3
mldy/Casp3
mldy, Casp3
tm1Flv/Casp3
tm1Flv, Casp3
mldy/
Casp3
tm1Flv, Casp3
tm1Flv/? , Casp3
mldy/? , and ?/? mice
between 2 and 3 months old. The images show that
Casp3
mldy/Casp3
mldy mice display severe abnormalities of
both inner-hair-cell (IHC), and outer-hair-cell (OHC)
stereocilia bundles (Fig. 5). The three organised rows of
OHCs seen in the organ of Corti of ?/? mice are not
observed in Casp3
mldy/Casp3
mldy animals (Fig. 5ai–di).
Fig. 3 ABR data from melody mutant mice. a Representative traces
from 12-week-old ?/? and Casp3
mldy/Casp3
mldy mice in response to
12-kHz tone-burst stimuli at decreasing stimuli levels. In the wild-
type mice, the ﬁve main ABR peaks can be seen in response to the
stimulus at levels down to 30 dB SPL. In the Casp3
mldy/Casp3
mldy
mice, no peaks are observed at any of the stimulus levels.
b Audiogram showing average ABR threshold levels for 12-week-
old ?/? and Casp3
mldy/Casp3
mldy mice (n = 5). The error bars
denote the standard error of the mean. Casp3
mldy/Casp3
mldy mice
showed no response to the highest stimulus level (90 dB SPL) at any
of the test frequencies (8, 12, 20, and 26 kHz). For graphical
representation, the Casp3
mldy/Casp3
mldy thresholds are plotted as
100 dB SPL. c Average ABR thresholds in response to a click
stimulus of ?/? (n = 10, with three aged 4 weeks and seven aged
8 weeks), Casp3
mldy/? (n = 20 with four aged 4 weeks and 16 aged
8 weeks), Casp3
tm1Flv/? (n = 12 with all aged 8 weeks), Casp3
mldy/
Casp3
mldy (n = 4 with one aged 4 weeks and three aged 8 weeks),
Casp3
tm1Flv/Casp3
tm1Flv (n = 4 with all aged 8 weeks), and
Casp3
mldy/Casp3
tm1Flv (n = 11 with all aged 8 weeks). All ?/?,
Casp3
mldy/? , and Casp3
tm1Flv/? mice had ABR thresholds between
15 and 30 dB SPL. No response to the highest stimulus level (90 dB
SPL) was seen in any of the Casp3
mldy/Casp3
mldy, Casp3
tm1Flv/
Casp3
tm1Flv,o rCasp3
mldy/Casp3
tm1Flv. For graphical representation,
thresholds are plotted as 100 dB SPL
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observed in Casp3
mldy/Casp3
mldy, Casp3
tm1Flv/Casp3
tm1Flv,
and Casp3
mldy/Casp3
tm1Flv when compared to wild–type
mice, including stereocilia fusion and hair cell loss. The
severity of hair cell degeneration varies along the cochlea,
although there is no observable pattern between specimens.
Some small areas of the organ of Corti are unaffected and
show what appears to be normal OHC stereocilia mor-
phology, and others totally lack OHC stereocilia. In
addition to the widespread degeneration, some of the
remaining OHC stereocilia appear to be fused at the tips,
and separate bundles also appear connected (Fig. 5aiii–
diii). Similar stereocilia abnormalities, including the con-
necting material between OHC bundles, were previously
reported in the B6.129S1-Casp3
tm1Flv/J -ull mice (Takah-
ashi et al. 2001); however, we cannot rule out that this
phenotype is due to an artefact. Extensive abnormalities
are also seen for IHCs. Most of the IHC stereocilia have
also fused together and are larger than normal size,
although IHC degeneration is not as severe or widespread
as that of the OHCs (Fig. 5aii–dii). These hair cell
abnormalities are not seen in the Casp3
mldy/? or
Casp3
tm1Flv/? mice (data not shown).
Histology
Histological examination of sagittal sections from the
cochlea of 8-week-old mice show reduced numbers of
spiral ganglion (SG) neurons in Casp3
mldy/Casp3
mldy,
Casp3
mldy/Casp3
tm1Flv, and Casp3
tm1Flv/Casp3
tm1Flv mice
(Figs. 6 and 7a). We have determined SG neuron density in
apical, mid, and basal turns of ?/?, Casp3
mldy/? ,
Casp3
mldy/Casp3
mldy,Casp3
tm1Flv/Casp3
tm1Flv,andCasp3
mldy/
Casp3
tm1Flv mice (Fig. 7a, b). There were no signiﬁcant dif-
ferences in SG neuron density between ?/? and Casp3
tm1Flv/
? mice in any of the turns of the cochlea. Casp3
mldy/?
appeared to show reduced SG density compared with
?/? and Casp3
tm1Flv/? mice in all turns of the cochlea, with
signiﬁcant differences seen when compared to Casp3
tm1Flv/
? intheapicalandmidturns(P\0.05).Casp3
mldy/Casp3
mldy
andCasp3
mldy/Casp3
tm1Flv mice showed signiﬁcantly reduced
SG neuron density in all cochlear turns when compared to
?/? and Casp3
tm1Flv/? (P\0.05). Casp3
mldy/Casp3
mldy SG
densitywaslowerthanthatofCasp3
mldy/? inallturnsbutwas
only statistically signiﬁcant in the basal turn (P\0.05).
Interestingly, the Casp3
tm1Flv/Casp3
tm1Flv mice showed a
reduction in density in the mid and basal turns compared to
?/? (P\0.05), but not in the apical turn where, in fact, SG
density was signiﬁcantly higher than in Casp3
mldy/? and
Casp3
mldy/Casp3
mldy (P\0.05). Finally, the SG neuron den-
sity in Casp3
mldy/Casp3
tm1Flv mice was lower than in
Casp3
tm1Flv/Casp3
tm1Flvandthiswasfoundtobesigniﬁcantin
the apical turns, although it is here that Casp3
tm1Flv/
Casp3
tm1Flv mice have a higher SG neuron density.
Overall, there appeared to be an apex-to-base gradient of
severity of effects on SG neuron density in the mutant
Fig. 4 Western blot analysis of cytoplasmic protein from
E17.5 heads of Casp3
tm1Flv/Casp3
tm1Flv, Casp3
mldy/Casp3
tm1Flv,
Casp3
tm1Flv/?, ?/?, C3H, Casp3
mldy/Casp3
mldy, and Casp3
mldy/?
mice (n = 3). a Average protein expression levels from each of the
genotypes with the standard error of the mean. Protein levels are
normalised with a-tubulin as a loading control. An ANOVA was
performed using Tukey HSD post hoc analysis. Signiﬁcant differ-
ences in protein levels are shown: * reduced compared to C3H or
?/? (P B 0.05); , reduced compared to Casp3
mldy/? (p B 0.05); §,
reduced compared to Casp3
mldy/Casp3
mldy (p B 0.05); and ¥, reduced
compared to Casp3
tm1Flv/? (p B 0.05). b An example Western blot
probed with the Caspase-3 antibody and the a-tubulin loading control
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123genotypes at 8 weeks of age. Density was shown to be
signiﬁcantly lower in both the basal and mid turns com-
pared to apical turns in the Casp3
tm1Flv/Casp3
tm1Flv and
Casp3
mldy/Casp3
tm1Flv mice (P\0.05); however, no dif-
ferences were seen between the basal and mid turns. The
same trend was seen in Casp3
mldy/Casp3
mldy, although
there were no signiﬁcant differences. We also analysed SG
neuron density at an earlier time point, P18, and found that
at this age there were no signiﬁcant reductions in any of the
genotypes (data not shown). Moreover, given our obser-
vations on the apex-to-base gradient of SG neuron density,
we analysed the expression of Caspase 3 across the cochlea
turn in wild-type, Casp3
mldy/? , and Casp3
mldy/Casp3
mldy
mice. We did not observe any apex-to-base gradient in
Caspase-3 expression that might underlie the relative
preservation of spiral ganglion cells in the apical regions
(data not shown). We also analysed the expression of
Caspase 7 for differences in expression across the cochlear
turn that might contribute to the loss of SG neurons in the
base, but again we did not observe any apex-to-base gra-
dient (data not shown).
Discussion
We have identiﬁed a new mutation, melody, from an ENU
recessive deafness screen, demonstrating a profound hear-
ing loss. Melody carries a nonconservative mutation at the
catalytic cysteine (amino acid 163) of Caspase 3. Caspase 3
is responsible either totally or in part for the cleavage of a
large number of cytoskeletal proteins such as gelsolin,
actin, and a-fodrin, proteins involved with cell cycle and
proliferation such as Rb and p27
kip1, and activating protein
kinases such as MEKK1 (reviewed in Earnshaw et al.
1999). In a number of cases, Caspase 7, another execu-
tioner caspase that shares a high level of homology with
Caspase 3, may take over the cleavage of substrates in its
absence. For some substrates such as a-fodrin, which is
Fig. 5 Scanning electron
micrographs showing abnormal
hair cell morphology in the
cochlea of Casp3
mldy/Casp3
mldy
(n = 3), Casp3
mldy/Casp3
tm1Flv
(n = 2), Casp3
tm1Flv/
Casp3
tm1Flv (n = 2), and
?/? mice (n = 2) aged
2–3 months. Panel (ai ) shows a
wild-type organ of Corti, and
three well-organised rows of
outer hair cells (OHC) and one
row of inner hair cells (IHC) are
visible. Casp3
mldy/Casp3
mldy
(bi), Casp3
mldy/ Casp3
tm1Flv
(ci ), and Casp3
tm1Flv/
Casp3
tm1Flv (di ) display OHC
degeneration and abnormalities
of the stereocilia bundles of
IHCs and OHCs. Panels (ai i )–
(di i ) show higher-magniﬁcation
images of the IHCs, and panels
(a iii)–(d iii) show higher-
magniﬁcation images of the
OHCs. Casp3
mldy/? (n = 3)
and Casp3
tm1Flv/? (n = 2)
mice were also analysed (data
not shown) but showed no
differences to wild-type
(see ‘‘Results’’)
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123heavily involved with plasma membrane blebbing, Caspase
3 is indispensible for apoptotic cleavage (Janicke et al.
1998), although for neuronal apoptosis to occur it must be
cleaved by both calpain and Caspase 3 at different sites
(Nath et al. 1996). Calpain has long been associated with
neuronal necrosis, and, interestingly, Caspase 3 has been
shown to be involved with the cleavage of calpastatin,
which in turn leads to reduced inhibition of calpain. Con-
versely, pro-Caspase 3 is a substrate of calpain, but instead
of processing it into the active subunits, cleavage results in
a truncation that reduces the chance of activation by ini-
tiator caspases (Wang 2000). It would be expected that the
lack of a catalytically active Caspase 3 in melody or null
homozygote mice leads to these pathways being compro-
mised, resulting in a lack of the necessary developmental
apoptosis in certain cell types in the organ of Corti and the
brain. Most noteworthy for this study, Morishita et al.
(2001) showed that Caspase 3 is expressed in spiral gan-
glion neurons during inner-ear development where it pre-
sumably plays some role in apoptosis.
The ENU melody mutation causes a similar phenotype
to Casp3 -ull mice. However, there are some differences in
severity. These differences may be due to the genetic
background of the mice. Casp3
tm1Flv-null mice were orig-
inally created on a 129/sv genetic background and dis-
played severe brain hyperplasia and consequently died
in utero or very shortly after birth (Kuida et al. 1996). The
null mice used in this study were created by outcrossing
heterozygous 129/sv null to C57BL/6 J for ten generations
before intercrossing to produce the B6.129S1-Casp3
tm1Flv/J
mouse line. These mice were reported to have a much less
severe phenotype than the 129/sv null; they displayed only
minor brain abnormalities but developed sensorineural
hearing loss due to degeneration of sensory cells (Takah-
ashi et al. 2001). Mice homozygote for a different null
allele, Casp3
tm1Kin, which were created and maintained on
a C57BL/6 J background, also developed deafness due to
degeneration of sensory hair cells and spiral ganglion
(Morishita et al. 2001). Abnormally low ratios of homo-
zygote null mice were not reported in these studies.
Fig. 6 Histological analysis of
the spiral ganglion in the melody
mutant. H&E stained sections
from the apical, mid, and basal
turns of the cochlea from
2-month-old mice of each
genotype are displayed. The
degeneration in the apical turns
is not as severe as the mid or
basal turns. Scale
bars = 100 lm
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123However, we maintained our null mice by outcrossing to
C3H and intercrossing progeny to produce Casp3
tm1Flv/
Casp3
tm1Flv animals. The number of Casp3
tm1Flv/
Casp3
tm1Flv animals surviving (18 of 159, 11.4%) was sig-
niﬁcantly lower than the 25% expected according to Men-
delian inheritance from a recessive mating scheme (v
2
P = 0.00007). As already shown, the percentage of
Casp3
mldy/Casp3
mldy mice, also maintained on C3H, was
very similar (11.3%), and we demonstrated for melody that
50% of 17.5-dpc homozygous embryos displayed severe
blebbing of the head, potentially contributing to prenatal
losses. It would appear that both mutations display embry-
onic lethality on a C3H background.
The lack of an ABR response reﬂecting a profound
hearing loss in Casp3
mldy/Casp3
mldy mice was already
apparent by 2 weeks of age. It was previously reported that
2-week-old Casp3
tm1Flv/Casp3
tm1Flv mice showed an
atypical ABR response to a 70-dB-SPL stimulus but
showed no response to a 100-dB-SPL stimulus by ﬁve
weeks (Takahashi et al. 2001). It is also documented that
Fig. 7 Analysis of spiral ganglion neuron densities between geno-
types and between cochlear turns. a Spiral ganglion neuron densities
for each genotype in the apical, mid, and basal turns of the cochlea are
presented. The number of spiral ganglion neurons were counted and
normalised to the area of Rosenthal’s canal in each section to provide
the spiral ganglion neuron density in mm
2. Error bars denote standard
error of the mean. Six sections from each genotype were analysed.
b Table of statistically signiﬁcant differences in spiral ganglion
neuron density in the apical, mid, and basal turns. An ANOVA was
performed using either Tukey HSD or Tamhane post hoc analysis
(see ‘‘Materials and methods’’)
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tm1Kin/Casp3
tm1Kin mice showed very
elevated but not absent ABR responses at four months of
age (Morishita et al. 2001). Both Casp3 knockouts were
analysed on a C57BL/6 background, a strain that shows
age-related hearing loss. Overall, the melody homozygotes
exhibited a hearing loss as profound as the knockout
mutations, particularly when taking into account that mel-
ody was analysed on a C3H hearing-sensitive background.
Degeneration and fusion of OHCs was reported in the
previous study of the Casp3
tm1Flv mutant (Takahashi et al.
2001). Moreover, Takahashi et al. reported some fusion of
IHC stereocilia, although this was not particularly exten-
sive and the bulk of IHC stereocilia appeared normal.
Interestingly, the fusion of IHC that we observed in the
Casp3
tm1Flv/Casp3
tm1Flv mice appears much more exten-
sive, affecting the bulk of inner-ear stereocilia. Takahashi
et al. (2001) also reported increased numbers of border
cells and persistence of the greater epithelial ridge, from
which border cells and inner hair cells develop in the organ
of Corti.
In the melody mutation we focused on its effects on
degeneration of spiral ganglion neurons and carried out a
detailed analysis of neuronal density in all genotypes
across the cochlear turns. Morishita et al. (2001) reported
degeneration of the spiral ganglion in the Caspase-3
knockout beginning at 30 days but did not quantify the
effect or investigate its distribution across the cochlear
turns. We have demonstrated that both homozygous
mutants and the compound mutant show extensive hyp-
ocellularity of spiral ganglion neurons in Rosenthal’s
canal at eight weeks of age. We made two important
observations. First, there is evidence of a gradient of
severity in Casp3
mldy/Casp3
mldy, Casp3
tm1Flv/Casp3
tm1Flv,
and the compound mutant, with the apical turns being
severely affected the least. As a consequence of this
observation, for both Caspase 3 and Caspase 7 we
examined whether there was any evidence of apex-to-base
gradients of expression in the cochlea but found none.
Second, we noted that melody heterozygotes appeared to
show some evidence of reductions in neuronal density in
the spiral ganglion. Although they did not display the
extent of hypocellularity that was seen in the melody
homozygotes, null homozygotes, or compound mutants,
the population of spiral ganglion neurons was signiﬁ-
cantly lower in apical and mid turns compared to that in
heterozygous knockout mice (Casp3
tm1Flv/?). Interest-
ingly, there is also some evidence to suggest that effect
on neuronal density is more severe in the compound
mutant (Casp3
mldy/Casp3
tm1Flv) compared to that in the
homozygous knockout, which would be consistent with
the melody mutation exerting a dominant negative effect.
Overall, our evidence indicates that the melody mutation
may show some dominant effects in the spiral ganglion,
although we have seen no dominant effects from ABR
measurements where auditory thresholds correspond to
wild type in the heterozygote. It is notable that we found
some reduction in protein levels in the melody heterozy-
gote (see ‘‘Results’’), though this was not signiﬁcant. The
reduced SG neuron density in melody heterozygotes is
also noteworthy given that heterozygotes show no hair
cell abnormalities or loss. The absence of any degenera-
tion of SG neurons at P18 for any genotype might suggest
that SG neuron loss is secondary to hair cell loss. How-
ever, our observations in melody heterozygotes would
indicate that the Caspase-3 mutant acts directly on the
spiral ganglion cells and not as a secondary consequence
of hair cell loss.
It is not inconceivable, given the nature of the melody
mutation, that mutant protein may bind, but not degrade,
and thus sequester substrates leading to dominant effects in
the heterozygote in some tissues. Indeed, the exact sub-
stitution caused by the melody mutation has been created
by targeted mutagenesis and is often used as a catalytically
inactive form of Caspase 3 for the study of caspase activity
in in vitro experiments (Bose and Clark 2005; Feeney and
Clark 2005; Gu et al. 1995; Kang et al. 2008; Van Criek-
inge et al. 1996). This catalytically inactive form has been
shown to fold into the active form and bind to substrates of
Caspase 3 but it is unable to cleave them due to the mutated
active site (Dejosez et al. 2008).
In conclusion, we have identiﬁed a new Caspase-3
mutation, leading to the alteration of the catalytically
active cysteine, and explored its effect on auditory func-
tion and the spiral ganglion in the inner ear. We have
demonstrated a gradient of effect in the spiral ganglion
across the cochlea turns and provided evidence that
melody may exert dominant effects, at least in the spiral
ganglion. The development of an in vivo model of the
cysteine 163 mutation should enhance our understanding
of the action of Caspase 3. In particular, given the
potential for this mutant to bind and sequester proteins, it
will be interesting to undertake a more comprehensive
phenotype analysis of this mutant across a range of tissues
in both heterozygote and homozygote mice; these exper-
iments are underway.
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